Who invested in AFYX Therapeutics?
AFYX Therapeutics's investors include EISMEA and Novo Holdings.
Who invested in AFYX Therapeutics
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2019, from 1 source
- Latest round
- Debt, $13MJun 2019
- Investors
- 2
The rounds
- Jun 2019
Founders and team
From AFYX Therapeutics's own website: 8 on the team.
- Dr. Claus J. Møller-San PedroBoard Member & CEO
- Pernille TræholtVP Chief Development Officer
- Michael N. RimikisVP Business Development & Medical Network
- Send Us A MessageVP Business Development & Medical Network
- Dr. Ole BaadsgaardChairman
- Fredrik D. KnudsenSenior Financial Director
- Mr. Søren KjærBoard Member
- Pia Møller-San PedroBoard Member
Everyone who backed them
EISMEAInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about AFYX Therapeutics
How much has AFYX Therapeutics raised?
AFYX Therapeutics has raised $13M across 1 round since 2019.
When did AFYX Therapeutics last raise?
AFYX Therapeutics's most recent round was a Debt of $13M in Jun 2019.
What was AFYX Therapeutics's biggest round?
Its most recent round, $13M in Jun 2019, is also its largest on record.
Who backed AFYX Therapeutics first?
AFYX Therapeutics's first round on record, in Jun 2019, was backed by EISMEA and Novo Holdings.
What stage is AFYX Therapeutics at?
AFYX Therapeutics's latest named round is a Debt, in Jun 2019.
Companies like AFYX Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.